MRD kinetics can predict the time to relapse after autologous stem cell transplantation (SCT) in chronic lymphocytic leukemia (CLL).

被引：0
|
作者：
Ritgen, M
Boettcher, S
Stilgenbauer, S
Dohner, H
Brueggeman, M
Pott, C
Raff, T
Schmitz, N
Hallek, M
Kneba, M
Dreger, P
机构：
[1] Univ Hosp Schleswig Holstein, Dept Med 2, Kiel, Germany
[2] Univ Hosp Ulm, Dept Med 3, Ulm, Germany
[3] Allgemeines Krankenhaus St Georg, Dept Hematol, Hamburg, Germany
[4] Univ Heidelberg Hosp, Dept Med 5, Heidelberg, Germany
[5] Univ Hosp Cologne, Dept Med 1, Cologne, Germany
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
714
引用
收藏
页码：211A / 212A
页数：2
相关论文
共 50 条
  • [1] Hematopoietic stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL).
    Horowitz, MM
    Montserrat, E
    Sobocinski, K
    Giralt, S
    Khouri, IF
    Schmitz, N
    BLOOD, 2000, 96 (11) : 522A - 522A
  • [2] Stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL):: Outcome and prognostic factors after autologous and allogeneic transplants.
    Esteve, J
    Montserrat, E
    Dreger, P
    Meloni, G
    Pavletic, S
    Catovsky, D
    Dearden, C
    Scimè, R
    Sutton, L
    Michallet, M
    Desablens, B
    Kimby, E
    Coiffier, B
    Brunet, S
    Sanz, MA
    Besalduch, J
    Caballero, D
    Juliusson, G
    Conde, E
    del Potro, E
    Schmitz, N
    BLOOD, 2001, 98 (11) : 482A - 482A
  • [3] Unmutated VH gene status predicts for inferior relapse-free survival after autologous stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL)
    Ritgen, M
    Lange, A
    von Neuhoff, N
    Stilgenbauer, S
    Bretscher, C
    Kneba, M
    Dreger, P
    BONE MARROW TRANSPLANTATION, 2002, 29 : S34 - S35
  • [4] Clinical significance of minimal residual disease (MRD), as assessed by different techniques, after stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL)
    Moreno, C
    Villamor, N
    Esteve, J
    Colomer, D
    Bosch, F
    Carnpo, E
    Montserrat, E
    BLOOD, 2005, 106 (11) : 571A - 571A
  • [5] Follow-up of chronic lymphocytic leukemia (CLL) patients who relapse after autologous stem cell transplantation (ASCT)
    Trisolini, SM
    Mauro, FR
    Capria, S
    Cimino, G
    De Propris, MS
    Proia, A
    Foa, R
    Meloni, G
    BLOOD, 2004, 104 (11) : 388B - 388B
  • [6] CD38 expression has no prognostic influence after autologous stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL)
    Schloe, U
    Viehmann, K
    Lange, A
    Ritgen, M
    Dreger, P
    BONE MARROW TRANSPLANTATION, 2002, 29 : S165 - S165
  • [7] Unmutated VH gene status retains its adverse prognostic influence after autologous stem cell transplantation (SCT) for chronic lymphocytic leukemia (CLL).
    Lange, A
    Ritgen, M
    Brüggemann, M
    Schmitz, N
    Kneba, M
    Dreger, P
    BLOOD, 2001, 98 (11) : 861A - 861A
  • [8] Hematopoetic stem cell transplantation (SCT) in chronic lymphocytic leukemia (CLL): A single institution experience.
    Esteve, J
    Villamor, N
    Bosch, F
    Lopez-Guillermo, A
    Rovira, M
    Urbano-Ispizua, A
    Colomer, D
    Carreras, E
    Montserrat, E
    BONE MARROW TRANSPLANTATION, 1998, 21 : S77 - S77
  • [9] Autologous stem cell transplantation for chronic lymphocytic leukemia
    Dreger, Peter
    Brand, Ronald
    Michallet, Mauricette
    SEMINARS IN HEMATOLOGY, 2007, 44 (04) : 246 - 251
  • [10] Analysis of prognostic factors on the outcome of autologous and allogeneic stem cell transplantations (SCT) for chronic lymphocytic leukemia (CLL).
    Michallet, M
    Brand, R
    Dreger, P
    Millighan, D
    Esteve, J
    Kimby, E
    Nicolini, F
    Apperley, J
    van Biezen, A
    Niederwieser, D
    BLOOD, 2001, 98 (11) : 859A - 860A
12345